43 results match your criteria: "University of Texas Health Science Center School of Nursing[Affiliation]"

Wisdom from Ignaz Semmelweis.

Nursing

October 2021

Katherine Frances O'Donnell is an advanced practice registered nurse at the University of Texas Health Science Center, San Antonio, Division of General and Minimally Invasive Surgery, and a faculty associate at the University of Texas Health Science Center School of Nursing Nurse Practitioner Program.

View Article and Find Full Text PDF

Risky health behaviors such as poor diet, physical inactivity are the main contributors to the development of diabetes, one of the major causes of death and disability in the United States. Online health communities provide new avenues for individuals to efficiently manage their health conditions and adopt a positive lifestyle. So far, analysis of health-related online social exchanges has focused solely on communication content and structure of social ties, ignoring implicit user intentions underlying communication exchanges.

View Article and Find Full Text PDF

Texas Team: Academic Progression and IOM Toolkit.

Nurs Educ Perspect

July 2018

About the Authors Helen Reid, EdD, RN, CNE, FAADN, is provost, Trinity Valley Community College Health Science Center, Kaufman, Texas. Kathryn Tart, EdD, RN, is founding dean and professor, University of Houston School of Nursing, Sugar Land, Texas. Mari Tietze, PhD, RN-BC, FHIMSS, is a professor, Doswell Endowed Chair in Nursing Informatics, and program director, Post-Baccalaureate Certificate in Interprofessional Informatics, Texas Woman's University T. Boone Pickens Institute of Health Sciences, Dallas Center. Nitha Mathew Joseph, PhD, RN, is an assistant professor and National Jonas Nursing Leader Scholar Alumna, University of Texas Health Science Center School of Nursing at Houston. Carson Easley, MS, RN, is director of nursing, Harris Center for Mental Health and IDD, Houston, Texas. The project in Part I was supported by a grant from the Robert Wood Johnson Foundation; Dr. Reid and Dr. Tart authored Part I of this article. The project in Part II was supported by a grant from the National Student Nurses Association Foundation; Dr. Mathew Joseph, Dr. Tietze, Ms. Easley, and Dr. Reid authored Part II of this article. For more information, contact Dr. Reid at

Background: The Institute of Medicine (IOM) Future of Nursing report, identified eight recommendations for nursing to improve health care for all Americans.

Aim: The Texas Team for Advancing Health Through Nursing embraced the challenge of implementing the recommendations through two diverse projects.

Method: One group conducted a broad, online survey of leadership, practice, and academia, focusing on the IOM recommendations.

View Article and Find Full Text PDF

Reducing blood pressure in acute decompensated heart failure.

Nurse Pract

June 2016

Daniel L. Arellano is critical care nurse practitioner at Division of Anesthesiology and Critical Care University of Texas MD Anderson Cancer Center, Houston, Tex. and an instructor of the Nursing Department at Family Health University of Texas Health Science Center School of Nursing, Houston, Tex.

View Article and Find Full Text PDF

The Alternative Peer Group: A Developmentally Appropriate Recovery Support Model for Adolescents.

J Addict Nurs

March 2017

Angela Nash, PhD, CPNP-PC, PMHS, University of Texas Health Science Center School of Nursing, Houston. Crystal Collier, PhD, LPC-S, The Council for Alcohol and Drugs, Houston, Texas.

Recovery as the goal for substance use disorder treatment has been a key component of the Substance Abuse and Mental Health Services Administration's mission for the past decade. Consistent with their mission, there is a call for research and development of recovery-oriented systems of care to support affected individuals through all stages of the recovery process. Evidence is emerging to support recovery practice and research for adults, but recovery-oriented models for adolescents are scant.

View Article and Find Full Text PDF

Penis Cancer: The Lived Experience.

Cancer Nurs

August 2017

Author Affiliations: Division of Nursing, The University of Texas MD Anderson Cancer Center, Houston (Dr Gordon); University of Texas Health Science Center School of Nursing, Houston (Dr Wood); College of Nursing, Texas Woman's University, Houston (Dr Malecha).

Background: This qualitative study examined the experiences of men with penis cancer. Cancer of the penis is a rare and debilitating disease, affecting 1 in 100 000 men in Western countries. Although much has been written about the medical treatment of the disease, little has been published about the experiences of men who have penis cancer.

View Article and Find Full Text PDF

Gliosarcoma is classified by the World Health Organization as a variant of glioblastoma. These tumors exhibit biphasic histologic and immunophenotypic features, reflecting both glial and mesenchymal differentiation. Gliosarcomas can be further classified into primary (de novo) tumors, and secondary gliosarcomas, which are diagnosed at recurrence after a diagnosis of glioblastoma.

View Article and Find Full Text PDF

Hope and mood changes throughout the primary brain tumor illness trajectory.

Neuro Oncol

January 2016

Department of Family Health, University of Texas Health Science Center School of Nursing, Houston, Texas (A.A.A.); Department of Family Health, The University of California, San Francisco, California (L.L.); Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (E.V.-B., T.S.A.); Department of Neuro-Oncology, National Institutes of Health, Bethesda, Maryland (M.R.G.); Department of Family Health, University of Texas Health Science Center School of Nursing, Houston, Texas (T.S.A.).

Background: The ambiguity of defining hope impacts the level of readiness faced by health care professionals treating patients with glioma, a disease with unpredictable outcomes. This study describes the report of hope and the relationship between hope and mood in adult brain tumor patients at various points in the illness trajectory.

Methods: This was a cross-sectional study with data collection including use of the Herth Hope Index (HHI), the Profile of Mood States-Short Form (POMS-SF), and clinical information.

View Article and Find Full Text PDF

Primary brain tumors and posterior reversible encephalopathy syndrome.

Neurooncol Pract

December 2014

Department of Neuro-Oncology , The University of Texas MD Anderson Cancer Center, Houston, Texas (C.K.-M., D.C., T.S.A., M.R.G.); Department of Family Health , The University of Texas Health Science Center School of Nursing , Houston, Texas (T.S.A.); Department of Pathology , The University of Texas MD Anderson Cancer Center, Houston, Texas (A.O.).

Background: Posterior reversible encephalopathy syndrome (PRES) is a neurotoxic encephalopathic state associated with reversible cerebral vasogenic edema. It is an increasingly recognized occurrence in the oncology population. However, it is very uncommon in patients with primary brain tumors (PBTs).

View Article and Find Full Text PDF

Impact of recall period on primary brain tumor patient's self-report of symptoms.

Neurooncol Pract

June 2014

Department of Family Health , University of Texas Health Science Center School of Nursing, Houston, Texas (T.S.); Department of Neuro-Oncology , The University of Texas: MD Anderson Cancer Center, Houston, Texas (T.S., E.V., A.A., M.R.G.); Department of Symptom Research , The University of Texas: MD Anderson Cancer Center, Houston, Texas (T.R.M.).

Background: Understanding the severity of symptoms is an integral part of patient care. The MD Anderson Symptom Inventory-Brain Tumor (MDASI-BT) was developed using a 24-hour recall period. The choice of recall period is dependent on the treatment and disease of interest.

View Article and Find Full Text PDF

Purpose: Accumulating evidence supports the contention that genetic variation is associated with neurocognitive function in healthy individuals and increased risk for neurocognitive decline in a variety of patient populations, including cancer patients. However, this has rarely been studied in glioma patients.

Experimental Design: To identify the effect of genetic variants on neurocognitive function, we examined the relationship between the genotype frequencies of 10,967 single-nucleotide polymorphisms in 580 genes related to five pathways (inflammation, DNA repair, metabolism, cognitive, and telomerase) and neurocognitive function in 233 newly diagnosed glioma patients before surgical resection.

View Article and Find Full Text PDF

This edition of CCR Focus provides critical reviews of several important areas in the field, including the application of findings from genomic investigations of brain tumors to improve diagnosis, clinical trial design, and ultimately optimizing individual patient treatment. Another article is a critical review provided by experts in the field that discusses the recent clinical trials using angiogenesis inhibitors, possible explanations for the results, and how to move forward. There is a concise discussion of the application of immunotherapy to brain tumors by key investigators in this field, reflecting the potential opportunities as well as the disease-specific challenges.

View Article and Find Full Text PDF

Agitation onset, frequency, and associated temporal factors in critically ill adults.

Am J Crit Care

July 2014

Ruth S. Burk is an assistant professor, Department of Acute and Continuing Care, University of Texas Health Science Center School of Nursing in Houston, Texas. Mary Jo Grap is Nursing Alumni Distinguished Professor, Adult Health and Nursing Systems Department, School of Nursing, and Curtis N. Sessler is the Orhan Muren Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia. Cindy L. Munro is associate dean for research and innovation and a professor, University of South Florida, College of Nursing, Tampa, Florida. Christine M. Schubert is an assistant professor, Department of Mathematics and Statistics, Air Force Institute of Technology, Wright-Patterson Air Force Base, Dayton, Ohio.

Background: Agitation is a frequent complication in critically ill adults, can result in life-threatening events for patients or care providers, and extends the hospital length of stay, thereby increasing hospital costs.

Objectives: To describe the incidence, onset, and temporal factors related to agitation in critically ill adults.

Methods: Data were collected for the first 5 days of stay of all adult patients consecutively admitted to a medical respiratory intensive care unit and a surgical trauma intensive care unit during a 2-month period.

View Article and Find Full Text PDF

Developing criterion-based competencies for tele-intensive care unit.

Dimens Crit Care Nurs

July 2015

Sarah Joy Schleifer, MSN, RN, ACNS-BC, CCRN, is a critical care CNS at Sharp Grossmont Hospital in La Mesa, California. She obtained her BSN and MSN from Point Loma Nazarene University in San Diego, California. She teaches new critical care RNs at a county-wide critical care intern program and is the marketing chair for the San Diego chapter of the AACN. Her areas of research interests include patient education, improvement of the patient experience, nurse/provider communication and patient centered care coordination. Karen Carroll, MS, RN, CCNS, CCRN, PCCN, is a critical care CNS at VA Medical Center San Diego Healthcare System. Both of Karen's graduate and undergraduate degrees are from San Diego State University (SDSU). She teaches undergraduate and graduate courses at SDSU in addition to PCCN review courses in the community. Ms Carroll's is currently working on research regarding inpatient cardiopulmonary arrests and the impact of a performance improvement based resuscitation training program to decrease cardiopulmonary arrests and improves survival at the VA San Diego Healthcare System. Marthe J. Moseley, PhD, MSN, RN, CCNS, is associate director of Clinical Practice in the Office of Nursing Services with the Department of Veterans Affairs. She holds a full Professor position at Rocky Mountain University of Health Professions in Provo, Utah and an Adjunct Professor position at the University of Texas Health Science Center School of Nursing at San Antonio, Texas. Dr Moseley obtained her BSN from Jamestown College and her MSN and PhD at the University of Texas Health Science Center in San Antonio, TX. She is on the editorial board for several critical care journals and is one of the team of three who write the "Introduction to Critical Care," a premier textbook for undergraduate students with course work in the ICU environment.

Over the last 5 years, telemedicine has developed nursing roles that differ from traditional bedside care. In the midst of this transition, current competency development models focused on task completion may not be the most effective form of proficiency validation. The procedure of competency creation for the role of tele-intensive care unit registered nurse requires a thoughtful process using stakeholders from institutional leadership to frontline staff.

View Article and Find Full Text PDF

A randomized trial of bevacizumab for newly diagnosed glioblastoma.

N Engl J Med

February 2014

From the University of Texas M.D. Anderson Cancer Center (M.R.G., T.S.A., J.S.W., P.D.B., I.W.T.-L., E.P.S., K.D.A.) and the University of Texas Health Science Center School of Nursing (T.S.A.), Houston; American College of Radiology (J.J.D., S.P., M.W.) and Thomas Jefferson University (M.W.-W.) - both in Philadelphia; the University of Chicago, Chicago (J.J.D.); Tel-Aviv Medical Center, Tel Aviv, Israel (D.T.B.); Cleveland Clinic, Cleveland (M.A.V.); the University of Utah, Salt Lake City (H.C.); Ohio State University, Columbus (A.C.); University of Wisconsin, Madison (R.J.); Mayo Clinic, Jacksonville, FL (K.A.J.); University of Virginia, Charlottesville (D.S.); Southeast Cancer Control Consortium, Winston-Salem, NC (V.W.S.); Barrow Neurologic Institute, Phoenix, AZ (D.G.B.); Emory University, Atlanta (W.J.C.); and the University of Maryland, Baltimore (M.P.M.).

Article Synopsis
  • The standard treatment for newly diagnosed glioblastoma includes temozolomide and radiotherapy, with bevacizumab approved for recurrent cases but its effectiveness in newly diagnosed patients is unclear.
  • In a randomized trial involving 978 patients, those receiving bevacizumab did not show significantly improved overall survival compared to those on placebo, with median survival times of 15.7 and 16.1 months, respectively.
  • However, the bevacizumab group exhibited longer progression-free survival (10.7 months vs. 7.3 months) but also experienced more serious side effects and a decline in quality of life and cognitive function.
View Article and Find Full Text PDF

Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma.

J Clin Oncol

November 2013

Terri S. Armstrong, University of Texas Health Science Center-School of Nursing; Terri S. Armstrong, Jeffrey S. Wefel, Mark R. Gilbert, Tito R. Mendoza, MD Anderson Cancer Center, Houston, TX; Meihua Wang, Minhee Won, Radiation Therapy Oncology Group Statistical Center; Maria Werner-Wasik, Thomas Jefferson University Hospital, Philadelphia, PA; Andrew Bottomley, Corneel Coens, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; David G. Brachman, Arizona Oncology Services Foundation and Barrow Neurological Institute, Phoenix, AZ; Ali K. Choucair, Mayo Clinic, Jacksonville, FL; Minesh Mehta, University of Maryland, Baltimore, MD.

Purpose: Radiation Therapy Oncology Group trial 0525 tested whether dose-intensifying temozolomide versus standard chemoradiotherapy improves overall survival (OS) or progression-free survival (PFS) in newly diagnosed glioblastoma. Tests of neurocognitive function (NCF) and symptoms (using the MD Anderson Symptom Inventory-Brain Tumor module; MDASI-BT) and of quality of life (European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ] -C30/BN20) examined the net clinical benefit (NCB) of therapy.

Patients And Methods: NCF tests (Hopkins Verbal Learning Test-Revised, Trail Making Test, and Controlled Oral Word Association), MDASI-BT, and EORTC QLQ-C30/BN20 were completed in a subset of patients.

View Article and Find Full Text PDF

Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.

J Clin Oncol

November 2013

Mark R. Gilbert, Kenneth D. Aldape, Terri S. Armstrong, Jeffrey S. Wefel, Anita Mahajan, and Paul D. Brown, University of Texas MD Anderson Cancer Center; Terri S. Armstrong, University of Texas Health Science Center-School of Nursing, Houston, TX; Meihua Wang and Minhee Won, Radiation Therapy Oncology Group Statistical Center, Philadelphia, PA; Roger Stupp and Monika E. Hegi, Lausanne University Hospitals, Lausanne, Switzerland; Kurt A. Jaeckle, Mayo Clinic Florida, Jacksonville, FL; Deborah T. Blumenthal, Tel Aviv Medical Center, Tel Aviv; Tzahala Tzuk-Shina, Rambam Medical Center, Haifa, Israel; Christopher J. Schultz, Medical College of Wisconsin, Milwaukee, WI; Sara Erridge, University of Edinburgh, Edinburgh, Scotland; Brigitta G. Baumert, Maastricht University Medical Center, Maastricht, the Netherlands; Kristen I. Hopkins, University Hospitals Bristol, Bristol, United Kingdom; Arnab Chakravarti, Arthur G. James Cancer Hospital/Ohio State University Comprehensive Cancer Center, Columbus, OH; Walter J. Curran Jr, Emory University Winship Cancer Center, Atlanta, GA; and Minesh P. Mehta, University of Maryland, Baltimore, MD.

Purpose: Radiotherapy with concomitant and adjuvant temozolomide is the standard of care for newly diagnosed glioblastoma (GBM). O(6)-methylguanine-DNA methyltransferase (MGMT) methylation status may be an important determinant of treatment response. Dose-dense (DD) temozolomide results in prolonged depletion of MGMT in blood mononuclear cells and possibly in tumor.

View Article and Find Full Text PDF

The shortage of nursing faculty has contributed greatly to the nursing workforce shortage, with many schools turning away qualified applicants because there are not enough faculty to teach. Despite the faculty shortage, schools are required to admit more students to alleviate the nursing shortage. Clinical groups in which preceptors are responsible for student learning extend faculty resources.

View Article and Find Full Text PDF

Congruence of primary brain tumor patient and caregiver symptom report.

Cancer

October 2012

Department of Family Health, University of Texas Health Science Center-School of Nursing, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Background: Evaluating the severity of symptoms in patients with primary brain tumors (PBTs) is important in clinical care and research but may be difficult due to patient neurocognitive (NC) impairment. This study was conducted to evaluate the congruence of symptom reporting in patient and caregiver dyads, examining potential impact of NC impairment and Karnofsky performance status (KPS).

Methods: PBT patients undergoing NC testing and their caregivers were included in this study.

View Article and Find Full Text PDF

This paper presents the main causes of heart failure (HF) and an update on the genetics studies on each cause. The review includes a delineation of the etiology and fundamental pathophysiology of HF and provides rational for treatment for the patient and family. Various cardiomyopathies are discussed, including primary cardiomyopathies, mixed cardiomyopathies, cardiomyopathies that involve altered cardiac muscle along with generalized multiorgan disorders, and various cardiovascular conditions, such as coronary artery disease (ischemic cardiomyopathy) and hypertension (hypertensive cardiomyopathy).

View Article and Find Full Text PDF

Symptom occurrence has been shown to predict treatment course and survival in cancer patients. The M. D.

View Article and Find Full Text PDF

Use of complementary and alternative medical therapy by patients with primary brain tumors.

Curr Neurol Neurosci Rep

May 2008

Department of Integrative Nursing Care, University of Texas Health Science Center School of Nursing, 6901 Bertner Avenue, Houston, TX 77030, USA.

The use of complementary and alternative medicine (CAM) is increasing. CAM includes mind-body interventions, biologically based therapies, energy therapies, and body-based methods. Primary brain tumors arise within the brain and have a poor prognosis when malignant.

View Article and Find Full Text PDF